Evidence map›Paper›PMID 40217999›Full record

ReviewHealthcare (Basel, Switzerland)2025

Bridging the Gap: From AI Success in Clinical Trials to Real-World Healthcare Implementation-A Narrative Review.

Rabie Adel El Arab, Mohammad S Abu-Mahfouz, Fuad H Abuadas, Husam Alzghoul, Mohammed Almari, Ahmad Ghannam, Mohamed Mahmoud Seweid

Abstract readReview
In one paragraph

Review in Healthcare (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rabie Adel El ArabDepartment of Health Management and Informatics, Almoosa College of Health Sciences, Al Ahsa 36422, Saudi Arabia.ORCID 0000-0002-3822-9236
Mohammad S Abu-MahfouzDepartment of Nursing, Almoosa College of Health Sciences, Al Ahsa 36422, Saudi Arabia.ORCID 0000-0003-4098-8693
Fuad H AbuadasDepartment of Nursing, Jouf University, Skakka 72388, Saudi Arabia.ORCID 0000-0002-4880-0862
Husam AlzghoulDepartment of Nursing, Almoosa College of Health Sciences, Al Ahsa 36422, Saudi Arabia.
Mohammed AlmariDepartment of Nursing, Almoosa College of Health Sciences, Al Ahsa 36422, Saudi Arabia.
Ahmad GhannamDepartment of Computer Science, Princess Sumaya University for Technology, Amman 11941, Jordan.ORCID 0000-0002-0838-3427
Mohamed Mahmoud SeweidDepartment of Nursing, Almoosa College of Health Sciences, Al Ahsa 36422, Saudi Arabia.ORCID 0000-0002-8556-9639

Funding

Almoosacollege of Health Sciences 3434
6 · The paper itself

Abstract

backgroundArtificial intelligence (AI) has demonstrated remarkable diagnostic accuracy in controlled clinical trials, sometimes rivaling or even surpassing experienced clinicians. However, AI's real-world effectiveness is frequently diminished when applied to diverse clinical settings, owing to methodological shortcomings, limited multicenter studies, and insufficient real-world validations.

objectiveThis narrative review critically examines the discrepancy between AI's robust performance in clinical trials and its inconsistent real-world implementation. Our goal is to synthesize methodological, ethical, and operational challenges impeding AI integration and propose a comprehensive framework to bridge this gap.

methodsWe conducted a thematic synthesis of peer-reviewed studies from the PubMed, IEEE Xplore, and Scopus databases, targeting studies from 2014 to 2024. Included studies addressed diagnostic, therapeutic, or operational AI applications and related implementation challenges in healthcare. Non-peer-reviewed articles and studies without rigorous analysis were excluded.

resultsOur synthesis identified key barriers to AI's real-world deployment, including algorithmic bias from homogeneous datasets, workflow misalignment, increased clinician workload, and ethical concerns surrounding transparency, accountability, and data privacy. Additionally, scalability remains a challenge due to interoperability issues, insufficient methodological rigor, and inconsistent reporting standards. To address these challenges, we introduce the AI Healthcare Integration Framework (AI-HIF), a structured model incorporating theoretical and operational strategies for responsible AI implementation in healthcare.

conclusionsTranslating AI from controlled environments to real-world clinical practice necessitates a multifaceted, interdisciplinary approach. Future research should prioritize large-scale pragmatic trials and observational studies to empirically validate the proposed AI Healthcare Integration Framework (AI-HIF) in diverse, real-world healthcare contexts.

Indexed as

AI ethicsalgorithmic biasartificial intelligencehealthcare integrationoperational efficiencyreal-world datareal-world evidence

Identifiers

PMID40217999
PMCPMC11988730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.